Delivery Order SPE2DB20D3101-SPE2DB24FRCC2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,243.15 firm fixed price delivery order is for the supply of 4559591749 - Levorphanol Tablets 2mg. The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,754.63 firm fixed-price delivery order is for the supply of 4561635024 Levorphanol 2 mg Tablets, with a completion date of July 31, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,918.22 delivery order contract is for the supply of Levorphanol 2 mg tablets, a pain management medication. The contract has a firm fixed price and does not have a set-aside designation, indicating open competition. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award, with ID SPE2DX22D0010|SPE2D823FCT61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,603.75 firm fixed-price delivery order is for the supply of Levorphanol Tablets 2mg, a pharmaceutical product. The contract has a completion date of January 11, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,211.60 firm fixed-price delivery order is for the supply of Levorphanol 2 mg tablets, a pain management medication. The contract has an ultimate completion date of May 30, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $5,754.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,336,717 units of the 2 mg Levorphanol tablet, a prescription pain medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of January 17, 2024. It was awarded on January 16, 2024, and does not have...
- This federal contract award is a delivery order (SPE2DB22FN44E) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Levorphanol 2 mg tablets. The contract has a ceiling value of $6,908.53 and an ultimate completion date of January 19, 2022. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award, identified as SPE2DB20D1109 and SPE2DB25FN97A, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,568,073,816 tablets of the pharmaceutical drug Levorphanol 2 mg, with a ceiling value of $3,969.02 and a performance period through April 30, 2025. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $11,211.60 firm fixed-price contract is for the delivery of 4565110806 - Levorphanol 2 mg Tablets - to the Defense Logistics Agency (DLA), a defense agency. The award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRCC2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,884.79 firm fixed-price delivery order is for the supply of 4,563,788,623 units of Levorphanol 2 mg tablets, with a performance period running through February 23, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 2/22/24 |